Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 872,166 |
|
|||||
| News | - | ||||||
| Day High | 3.64 | Low High |
|||||
| Day Low | 3.39 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Verastem Inc | VSTM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.20 | -5.49% | 3.44 | 18:59:12 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.59 | 3.39 | 3.64 | 3.40 | 3.64 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,184 | 872,166 | US$ 3.51 | US$ 3,058,994 | - | 3.39 - 14.22 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:12 | formt | 290 | US$ 3.44 | USD |
Verastem Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 86.26M | 25.30M | - | 0 | -87.37M | -3.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Verastem News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VSTM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.05 | 4.0819 | 3.39 | 3.80 | 943,370 | -0.61 | -15.06% |
| 1 Month | 11.75 | 13.52 | 3.39 | 4.49 | 1,772,092 | -8.31 | -70.72% |
| 3 Months | 9.99 | 13.52 | 3.39 | 5.32 | 661,592 | -6.55 | -65.57% |
| 6 Months | 7.43 | 14.22 | 3.39 | 6.38 | 375,186 | -3.99 | -53.70% |
| 1 Year | 11.38 | 14.22 | 3.39 | 7.19 | 269,062 | -7.94 | -69.77% |
| 3 Years | 47.64 | 59.22 | 3.39 | 19.81 | 1,347,445 | -44.20 | -92.78% |
| 5 Years | 14.88 | 59.22 | 3.39 | 22.24 | 2,137,779 | -11.44 | -76.88% |
Verastem Description
| Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. The company's first commercial product, COPIKTRA (duvelisib) is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma after at least two prior systemic therapies. The company's product pipeline candidate, defactinib, is a focal adhesion kinase inhibitor in development for the treatment of cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic, and other advanced cancers. |
